Skip to main content

Table 1 Clinical and Demographic Description of PD patients

From: Cognitive characteristics in Chinese non-demented PD patients based on gender difference

 

PD (n = 60)

Male PD (n = 30)

Female PD (n = 30)

Age(yr)

59.05 ± 9.55

58.67 ± 10.23

59.43 ± 8.98

Age of onset(yr)

54.97 ± 10.42

54.4 ± 11.38

55.53 ± 9.53

Handedness(L/R)(n)

0/60

0/30

0/30

Educational level(yr)

12.86 ± 2.97

13.1 ± 2.94

12.61 ± 3.03

Duration of illness(yr)

4.22 ± 5.33

4.37 ± 4.85

4.07 ± 5.85

Hoehn and Yahr stage

1.73 ± 0.8

1.92 ± 0.81

1.54 ± 0.76

UPDRS—Part III (“off” medication)

24.81 ± 12.04

24.42 ± 13.32

25.19 ± 10.92

Medication(n)

31/60

15/30

16/30

 MAOI-B

4

1

3

 Dopamine agonist

7

2

5

 Levodopa

9

5

4

 Levodopa and dopamine agonist

12

7

5

 Levodopa and MAOI-B

2

1

1

 Dopamine agonist and MAOI-B

1

1

0

Medication(equivalent)

472.74 ± 293.16

483.73 ± 293.69

460.28 ± 302.34

BDI

12.44 ± 9.06

12.48 ± 10.88

12.39 ± 7.08

MMSE

28.98 ± 1.07

28.97 ± 0.81

29 ± 1.29

  1. Note. UPDRS Unified parkinson’s disease rating scale, MAOI-B Monoamine oxidase inhibitor type B, BDI Beck depression inventory, MMSE Mini-mental state examination